Transurethral Resection of the Prostate Shows Significant Improvement in Quality of Life Indicators Three Months Post-Operatively
Friday, 01 October 2004 BERKELEY, CA (UroToday Inc.) - Benign prostatic hyperplasia (BPH) is the most common benign tumor in men and accounts for bothersome lower urinary tract symptoms in many.
read more
|
PSA No Longer Useful Diagnostic Marker of Prostate Cancer
Monday, 13 September 2004 NEW YORK (Reuters Health) - Dependence on serum levels of prostate specific antigen (PSA) as a marker of cancer has led to overly zealous treatment of men with prostate hyperplasia, investigators at Stanford University report.
read more
|
Treating Voiding Dysfunction with Sacral Nerve Stimulation Can Improve Depression and Quality of Life
Tuesday, 17 August 2004 BERKELEY, CA (UroToday Inc.) - There can be a significant decrease in quality of life and increasing depression with unresolved voiding dysfunction.
read more
|
Sacral Nerve Stimulation for Voiding Dysfunction Improves Quality of Life
Monday, 16 August 2004 NEW YORK (Reuters Health) - Findings from a new study indicate that treating refractory voiding dysfunction with sacral nerve stimulation produces significant improvements in depression and health-related quality of life (HRQOL).
read more
|
International Consultation on Incontinence Questionnaire (ICIQ) Proven to be a Generalizble Outcome Measure for Use in Practice and Research
Thursday, 12 August 2004 BERKELEY, CA (UroToday Inc.) - The International Consultation on Incontinence (ICI) initiated the development of a self-completion questionnaire (ICIQ)in 1998.
read more
|
TURP Safe after Brachytherapy for Prostate Cancer
Friday, 06 August 2004 NEW YORK (Reuters Health) - After an interval of 6 months or longer, transurethral resection of the prostate (TURP) can be safely conducted in men who have undergone brachytherapy as the sole treatment for localized prostate cancer, according to French researchers.
read more
|
A Meta-Analysis of Transurethral Needle Ablation of the Prostate Suggests Effective Symptomatic Improvement
Thursday, 29 July 2004 BERKELEY, CA (UroToday Inc.) - Transurethral resection of the prostate (TURP) remains the gold standard for treatment of symptomatic benign prostatic hyperplasia (BPH).
read more
|
Meta-Analysis Suggests Similar Outcomes for BPH Treatment by Transurethral Electrovaporization vs. Transurethral Resection of the Prostate
Thursday, 22 July 2004 BERKELEY, CA (UroToday Inc.) - Transurethral resection of the prostate (TURP) has long been considered the standard of care for definitive treatment of symptomatic benign prostatic hyperplasia (BPH).
read more
|
Sexual Side Effects with Finasteride Less Common Than Thought
Tuesday, 20 July 2004 NEW YORK (Reuters Health) - Contrary to what has been reported in clinical trials, treatment with finasteride for androgenetic alopecia appears to have minimal effect on sexual function, Italian researchers report.
read more
|